Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy

Cited by (999)

Items 901–999 of 999

1. Enzymatic synthesis of methyl derivatives of L -tryptophan selectively labeled with hydrogen isotopes
   Elżbieta Winnicka, Marianna Kańska · 2018 · Applied Radiation and Isotopes
2. Quantification of Linrodostat and its metabolites: Overcoming bioanalytical challenges in support of a discovery Indoleamine 2,3 dioxygenase program
   Lorell Discenza, Aaron Balog, Christine Huang, Robin Moore, Asoka Ranasinghe, Tai-an Lin, Celia J D’Arienzo, Timothy V. Olah · 2022 · Journal of Chromatography B
3. Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer
   Liang Shi, Rui Duan, Qiong Jia, Wenyu Wu, Jianming Zhou, Shaohua Li, Hao Zhang, Xue Xue · 2022 · Frontiers in Oncology
4. Indoleamine 2,3-Dioxygenase (IDO) and Cancerous Cells
   Amir Reza Safdarian, Pooya Farhangnia, Nima Rezaei · 2023 · Springer eBooks
5. High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients
   Kashif Asghar, Iftikhar Ali Rana, Muhammad Abubakar, Kinza Hasham, Muhammad Tahseen, Sundus Bilal, Shafqat Mehmood, Asim V. Farooq, Kashif Siddique, Asif Loya · 2023 · Asian Pacific Journal of Cancer Prevention
6. Indoleamine 2,3-dioxygenase
   Michele Coluccia, Daniela Secci, Paolo Guglielmi · 2023 · Elsevier eBooks
7. Immunomodulating Effect of Ethyl Pyruvate on Nonsyngenic Transplanted Tumor in Mice
   Л. А. Богданова, T. S. Morozkova, В. И. Каледин, Valeriy P. Nikolin, Н. А. Попова · 2013 · Bulletin of Experimental Biology and Medicine
8. Dual Effects of Indoleamine 2,3-Dioxygenase Inhibitors on the Therapeutic Effects of Cyclophosphamide and Cycloplatam on Ehrlich Ascites Tumor in Mice
   Л. А. Богданова, T. S. Morozkova, S. A. Amitina, Dmitrii G. Mazhukin, Valeriy P. Nikolin, Nelly A. Popova, В. И. Каледин · 2014 · Bulletin of Experimental Biology and Medicine
9. Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated
   Nicholas Booth, Wells Brockbank, Samuel Oh, Karl Kingsley · 2012 · Journal of Molecular Pathophysiology
10. Preventing Hyperglycemia and Tissue Injury in Diabetes: The Dynamic Role of 2,3 Indoleamine Dioxygenase (IDO) in Diabetes and Its Complications
    Manuela Bartoli, Folami Lamoke, Babak Baban · 2013 · Advances in predictive, preventive and personalised medicine
11. Role of IDO in Dendritic Cell Differentiation and Function in Cancer
    Alexey Popov, Joachim Ludwig Schultze · 2009 · Springer eBooks
12. Role of the Immune Tolerance-Inducing Molecule Indoleamine 2,3-Dioxygenase in Gynecologic Cancers
    Kazuhiko Ino Yuko Tanizaki · 2013 · Journal of Cancer Science & Therapy
13. The Metabolic Achilles Heel: Tumor Cell Metabolism as Therapeutic Target
    Eva Gottfried, Katrin Peter, Marina P Kreutz · 2010 · Springer eBooks
14. Tumor-Associated Macrophages in Cancer Growth and Progression
    Alberto Mantovani, Paola Allavena, Antonio Sica · 2007 · Elsevier eBooks
15. Promising therapeutics of gastrointestinal cancers in clinical trials
    Lingling Du, Zheng Che, Andrea Wang‐Gillam · 2017 · Journal of Gastrointestinal Oncology
16. Identification of a Novel Indoleamine 2,3-Dioxygenase Inhibitor Bearing an Eight-Membered Ring Fused Indole Scaffold and Its Structure-Activity Relationship
    Shinsuke Inuki, Hiroaki Ohno, Ayuta Yamaguchi, Katsumi Ohta, Shinya Oishi, Akira Asai · 2021 · Heterocycles
17. Suppression of RIP1 activity via S415 dephosphorylation ameliorates obesity‐related hepatic insulin resistance
    Yanping Wang, Jie Xiong, Yanmei Yuan, Ping Wu, Chao Peng, Yibing Wang, Junxi Lu, Yue Yin, Junting Xu, Suzhen Chen et al. · 2022 · Obesity
18. Effect of crosstalk among conspirators in tumor microenvironment on niche metastasis of gastric cancer.
    Zhongbo Zhu, Lijuan Shi, Yawei Dong, Yanmei Zhang, Fan Yang, Jingjing Wei, Minfeng Huo, Peiqing Li, Xiping Liu · 2022 · PubMed Central
19. Role of Tumor‐Associated Macrophages (TAM) in Cancer Related Inflammation
    Antonio Sica, Chiara Porta · 2010
20. Differential targeting of tryptophan catabolism in tumors and in tumor-draining lymph nodes by stereoisomers of the IDO inhibitor 1-methyl-tryptophan
    Alexander J. Muller, Richard A. Metz, George C. Prendergast · 2007 · International Congress Series
21. Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in stage III non-small cell lung cancer.
    Ben Creelan, G. Bepler, S. Antonia, Timothy J. Garrett, Hatem Hussein Soliman · 2011 · Journal of Clinical Oncology
22. Modes of Chemically Induced Cell Death
    Toshihiko Aki, Kana Unuma, Takeshi Funakoshi, Koichi Uemura · 2023 · Elsevier eBooks
23. Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD)
    Susie O. Lee, Eung-Won Kim, Haeri Lee, Sun-Ung Lim, Chan Kwon Jung, Young‐Ju Kang, Gyung-Ah Jung, Il‐Hoan Oh · 2025 · International Journal of Molecular Sciences
24. Indoleamine 2,3-dioxygenase-1 expression in non-small-cell lung cancer: analyses of prevalence, clinical correlations and prognostic impact in 2 large patient cohorts
    Francesco Agustoni, Hui Yu, Kim E. Ellison, Derek E. Smith, Paul L.R. Mitchell, Gareth Rivalland, Rafał Dziadziuszko, Dexiang Gao, Shengxiang Ren, Christopher J. Rivard et al. · 2025 · Frontiers in Immunology
25. Indoleamine 2,3-Dioxygenase Regulates Placental Trophoblast Cell Invasion
    Yoshiki Kudo, Jun Sugimoto · 2025 · International Journal of Molecular Sciences
26. Bridging autophagy and endolysosomal dysfunction: Role of bridging integrator 1 in Alzheimer’s disease
    Julia C. Duckhorn, Doo Kyung Kim, Yu‐Wen Alvin Huang · 2025 · Neural Regeneration Research
27. Artemether and Euphorbia factor L9 suppress kynurenine production through distinct effects on tryptophan metabolism
    A. Capatina, T. Czechowski, Charlotte Plunkett-Jones, T. Tonon, I. Kourtzelis, B. Lichman, W. Brackenbury, I. Graham, Dimitris Lagos · 2025 · bioRxiv
28. RIP kinase inhibition with Necrostatin-1 improves human marginal mass islet graft survival and function for the management of type 1 diabetes
    Saloni Aggarwal, Nerea Cuesta-Gomez, Joy Paramor, Sandra Kelly, Kateryna Polishevska, K. Seeberger, Jessica Worton, Purushothaman Kuppan, Andrew R. Pepper · 2026 · Cell Death and Disease
29. Total Synthesis and Biological Evaluation of Exiguamines
    Seungjoo Noh, Jisook Park, Yeehwan Kim, Venkata Ramanan Krishnamurthy, Chang-Ki Min, Eun Young Choi, Chulbom Lee · 2026 · JACS Au
30. Engineered indoleamine 2,3-dioxygenase variant: Oxidative activation of prodrug indole-3-acetic acid against cancer cells for targeted therapy
    Liru Liu, Wanfang Li, Sheng Ye · 2026 · Molecular Therapy Oncology
31. IDO in Immune Escape
    Alexander J. Muller, Courtney Smith, Richard A. Metz, George C. Prendergast · 2013 · Elsevier eBooks
32. Small-Molecule Inhibitors of Necroptosis
    Colleen R. McNamara, Alexei Degterev · 2014 · Springer eBooks
33. Ido serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells
    Aikou Okamoto, Takashi Nikaido, Kazunori Ochiai, Satoshi Takakura, Miho Takao, Misato Saito, Yuko Aoki, Nobuya Ishii, Nozomu Yanaihara, Kyosuke Yamada et al. · 2007 · International Congress Series
34. Inflammatory programming and immune modulation in cancer by IDO
    Courtney Smith, George C. Prendergast · 2013 · Atlas of Genetics and Cytogenetics in Oncology and Haematology
35. Realizing the promise of breast cancer vaccines
    Hatem H. Soliman, Jackson Jackson · 2012 · Vaccine Development and Therapy
36. Indoleamine2,3-DioxygenaseExpressioninHumanCancers: Clinical and Immunologic Perspectives
    Jessica Godin-Ethier, Laïla‐Aïcha Hanafi, Ciriaco A. Piccirillo · 2011
37. 3-Ethenyl-1-(4-methylphenylsulfonyl)-1H-indole
    Julio Zukerman-Schpector, Glaudeston Dutra Wulf, Helio Alexandre Stefani, Stanley N. S. Vasconcelos, Seik Weng Ng, Edward R. T. Tiekink · 2012 · Acta Crystallographica Section E Structure Reports Online
38. Indoleamine 2,3-dioxygenase 1 modulates the immuneresponse; the new therapeutic targets of this drug
    Yasuko Yamamoto, Yuki Murakami, Masato Hoshi, Kuniaki Saito · 2013 · Folia Pharmacologica Japonica
39. indoleamine 2,3-dioxygenase
    Hatem Hussein Soliman · 2014 · Springer eBooks
40. Clinical Trials Targeting the Kynurenine Pathway
    Melanie Anne Sheen, Hatem H. Soliman · 2015 · Springer eBooks
41. Serum neopterin concentrations and tryptophan degradation pattern in patients with late stage larynx carcinoma
    Ayşe Başak Engin, Rıza Önder Günaydın, Sacit Altuğ Kesikli, Dietmar Fuchs, Ali Şefik Hoşal · 2017 · Pteridines
42. Regulation of Tumor Progression and Metastasis by Bone Marrow-Derived Microenvironments
    Tina El Rayes, Dingcheng Gao, Nasser Khaled Altorki, Thomas R. Cox, Janine Terra Erler, Vivek Mittal · 2017 · Springer eBooks
43. Tumor-associated Macrophages in Cancer Growth and Progression
    Alberto Mantovani, Maria Rosaria Galdiero, Paola Allavena, Antonio Sica · 2013 · Elsevier eBooks
44. A privileged dual action Alzheimer's disease therapeutic platform targeting immunopathic and proteopathic mechanisms: (E)-3-styrylindoles as inhibitors of indoleamine 2,3-dioxygenase-mediated tryptophan metabolism and β-amyloid aggregation
    Brendan Kelly, Elena Diez‐Cecilia, Luzhe Pan, Braden Sweeting, Laura Villar, Alexander Kreft, Mayuri Gupta, Shea L. Johnson, Donald Fredric Weaver · 2022 · Canadian Journal of Chemistry
45. Synthesis, activity exploration, molecular docking, and affinity assessment of theophylline derivatives as inhibitors targeting IDO1
    Ziyuan Wu, Songmao Liang, Shunhua Hu, Yimian Wang, Longfei Mao, Xixi Hou, Jianxue Yang · 2025 · Heterocyclic Communications
46. IDO Pathway
    David H. Munn, Andrew L. Mellor · 2013 · Elsevier eBooks
47. Indoleamine 2,3-Dioxygenase Amino Acid Metabolism and Tumour-Associated Macrophages: Regulation in Cancer-Associated Inflammation and Immune Escape
    George C. Prendergast, Richard A. Metz, Mee Young Chang, Courtney Smith, Alexander J. Muller, Suzanne Ostrand‐Rosenberg · 2011 · Springer eBooks
48. Immune Escape: Role of Indoleamine 2,3-Dioxygenase in Tumor Tolerance
    Jessica B. Katz, Alexander J. Muller, Richard A. Metz, George C. Prendergast · 2009 · Springer eBooks
49. Targeted siRNA Delivery Methods for RNAi-Based Therapies
    Di Chen · 2013 · Scholarship@Western (Western University)
50. Tolerancia inmunológica, un recorrido en el tiempo: ¿cómo discriminar entre lo propio y lo extraño?
    Heber Siachoque, Oscar Valero, Iglesias G. Antonio · 2013 · Revista Colombiana de Reumatología
51. Modes of Chemically Induced Cell Death
    Toshihiko Aki, Kanako Noritake, Takeshi Funakoshi, Kenichiro Uemura · 2014 · Elsevier eBooks
52. IDO/TDO Inhibition in Cancer
    George C. Prendergast, William J. Malachowski, Arpita Mondal, Peggy Scherle, Alexander J. Muller · 2017 · Springer eBooks
53. Regulatory T cells
    Vaia Florou, Breelyn Ann Wilky · 2018 · Springer eBooks
54. GM-CSF Gene-Transduced Prostate Cancer Vaccines: GVAX
    Lalit R. Patel, Jonathan W. Simons · 2010 · Springer eBooks
55. Endometrial Cancer: Indoleamine 2,3-Dioxygenase as a Prognostic Indicator
    Kazuhiko Ino, Eiko Yamamoto, Kiyosumi Shibata, Hiroaki Kajiyama, Akihiro Nawa, Fumitaka Kikkawa · 2009 · Springer eBooks
56. CD137/CD137 Ligand in Tumor and Viral Immunotherapy
    Ignacio Melero, Oihana Murillo, Iñigo Tirapu, Eduardo Huarte, Ainhoa Arina, Laura Arribillaga, Juan José Lasarte · 2007 · Springer eBooks
57. Caracterização do genoma e da resposta imune no microambiente tumoral de neoplasias PTEN-deficientes
    Thiago Vidotto · 2019
58. Molecular and Metabolic Cues of the Key-Lock Paradigm Dictating Immunogenic Cell Death
    Jonathan M. Pitt, Marie Vétizou, Oliver Kepp, Guido Kroemer, Laurence Zitvogel · 2014 · Springer eBooks
59. NEGATIVE MODULATION OF REGULATORY T CELLS AND PROMOTION OF THE TUMORICIDAL ACTIVITY OF DENDRITIC CELLS IN CANCER: A DOUBLE-EDGED STRATEGY
    Collin J. LaCasse · 2011 · UA Campus Repository (The University of Arizona)
60. Development of Vaccine Therapy for Pancreas Cancer
    Dung Thi Le, Elizabeth M. Jaffee, Dan A. Laheru · 2008 · Springer eBooks
61. Análise comparativa do mecanismo imunorregulador gerado pela indoleamina 2,3 dioxigenase (IDO) e interferon-gama (IFN-g) na interface materno-placentária entre mães que receberam transplante renal e mães saudáveis.
    Karen Matias do Prado · 2012
62. Models for Immunotherapy and Cancer Vaccines
    Roland Meisel, Anja Tröger, Thomas Moritz, Dagmar Dilloo · 2007 · The Cancer Handbook
63. Concentrações de ácidos graxos e de aminoácidos em tecido tumoral e tecido normal adjacente de pacientes com carcinoma espinocelular de mucosa de cabeça e pescoço
    Izabel de Arruda Leme · 2008
64. Avaliação da influência de hormônios e citocinas na expressão da indoleamina 2,3-dioxigenase, em cultivo celular de placenta e embrião murino e de ratas Wistar pela citometria de fluxo
    Maria Letícia Baptista Salvadori · 2011
65. Avaliação da influência da expressão da indoleamina 2,3-dioxigenase no ciclo celular de células placentárias e embrionárias murinas e de ratas em cultivo celular, frente à ação de hormônios e citocinas
    Graziela Menck Ferreira Santos · 2012
66. Mycoplasma and tumors: synergistic effect on human monocyte-derived dendritic cells immunosuppressing activity
    Giardino Torchia · 2008 · Università degli Studi di Napoli Federico II
67. Regulação cruzada entre peroxidases e indolamina 2,3 dioxigenase no controle da metabolização do triptofano
    Sabrina Sayori Okada · 2011
68. Tryptophan Metabolite 3-Hydroxyanthranilic Acid Augments TRAIL-Induced Apoptosis in Activated T Cells
    S. Seo · 2011 · Journal of Life Science
69. Down-regulation of the indoleamine 2,3-dioxygenase (IDO) transcription by tryptophan analogues
    Takeaki Okamoto, S. Toné, H. Kanouchi, F. Ohyama, Y. Minatogawa · 2007 · International Congress Series
70. Tumor-Induced Immune Dysfunction: Mechanism and Therapeutic Strategies
    Mikael Hanson · 2007 · Figshare
71. International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine
    Anna Teresa Alberobello · 2007
72. Bridging Integrator 1 (BIN1)
    James C. Turton, Kevin Morgan · 2013 · Springer eBooks
73. Kynurenines in neurological disorders
    Gillian Mackay · 2007 · Enlighten: Theses (The University of Glasgow)
74. Clinical implications and genetic regulation of indoleamine 2,3-dioxygenase serum activity
    Annika Raitala · 2009 · Tampere University Institutional Repository (Tampere University)
75. Strategies that are Mediated by Tumor Cells
    Gabriel A. Rabinovich, Dmitry I. Gabrilovich, Eduardo M. Sotomayor · 2007
76. Model of Tryptophan Metabolism, Readily Scalable Using
    Anne-Kristin Stavrum, Ines Heiland, Stefan Schuster, Pål Puntervoll, Mathias Ziegler, Fromthe ‡ DepartmentofInformatics · 2013
77. Borrelidin, a threonyl-tRNA synthetase inhibitor, is a potent immunosuppressive and anti-inflammatory agent
    Nadya Ogloff · 2013 · cIRcle (University of British Columbia)
78. Mechanisms of selective immunosuppressive effects of indoleamine 2, 3-dioxygenase and borrelidin
    Darya Habibi · 2011 · cIRcle (University of British Columbia)
79. Expressão da enzima Indoleamina-2,3-dioxigenase em neoplasias mamárias de cães
    Rafael Magdanelo Leandro · 2016
80. Antimikrobieller und immunmodulatorischer Effekt von Tr yptophanmetaboliten des Kynureninpfades
    Klaus Pfeffer · 2012
81. Experimental Models to Study the Kynurenine Pathway
    Anthony R. Guastella, Sharon K. Michelhaugh, Sandeep Mittal · 2015 · Springer eBooks
82. Influência do estrógeno e do interferon γ sobre a expressão da indoleamina-2,3-dioxigenase em cultura de células de placenta e embriões de ratas Wistar
    Maria Letícia Baptista Salvadori, Pedro Kastein Faria da Cunha Bianchi, Bernadete de Lourdes Liphaus, Erika Zolcsak de Sousa, Renata Santos Silva, José Roberto Kfoury · 2015 · Pesquisa Veterinária Brasileira
83. Concentrações de ácidos graxos e de aminoácidos em tecido tumoral e tecido normal adjacente de pacientes com carcinoma espinocelular de mucosa de cabeça e pescoço
    Campus de Ribeirão Preto · 2008
84. CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
    Lena M. Kranz, Matthias Birtel, Lina Hilscher, Christian R. Grunwitz, Jutta Petschenka, Fulvia Vascotto, Mathias Vormehr, Ralf-Holger Voss, Sebastian Kreiter, Mustafa Diken · 2016 · Human Vaccines & Immunotherapeutics
85. Clinical perspectives in cancer vaccines for hematological diseases
    Maurizio Chiriva‐Internati, Leonardo Mirandola, Marjorie Jenkins · 2013 · CRC Press eBooks
86. REVISIONES El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones virales crónicas The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases
    Carlos Alfaro, Oihana Murillo, Iñigo Tirapu, Arantza Azpilicueta, Eduardo Huarte, Ainhoa Arina, Laura Arribillaga, Maurizio Bendandi, Jesús Prìeto, Juan José Lasarte et al. · 2006
87. Indoleamine 2,3-Dioxygenase in Immune Escape: Regulation and Therapeutic Inhibition
    Alexander J. Muller, George C. Prendergast · 2007 · Elsevier eBooks
88. The Future in Ovarian Cancer: Advances in Immunotherapies
    Amani Makkouk, Cariad Chester, Holbrook E K Kohrt · 2016 · Springer eBooks
89. The conservation of suppressor of Cytokine Signalling 3 in mediating intestinal homeostasis
    Emily Smith · 2016 · Lancaster EPrints (Lancaster University)
90. INDOLEAMINE 2, 3-DIOXYGENASE: POTENTIAL IN CANCER IMMUNOTHERAPY
    Abdul Majid Qureshi, Kaenat Nasir, Amnah Mahroo, Bilal Zulfiqar, Kashif Asghar · 2013
91. The role of inflammation and SPARC (secreted protein acidic and rich in cysteine) in colorectal tumourigenesis
    Shuyi K. Fu · 2016 · UWA Profiles and Research Repository (UWA)
92. Application of Antigen Cross-Presentation Research into Patient Care
    2017 · Frontiers research topics
93. Immune Checkpoint Combinations with Inflammatory Pathway Modulators
    Nicholas C. DeVito, Michael A. Morse, Brent Allen Hanks, Jeffery M. Clarke · 2017 · Current cancer research
94. Overcoming Immune Suppression in the Tumor Microenvironment: Implications for Multi-modal Therapy
    Theodore S. Johnson, David H. Munn · 2017 · Springer eBooks
95. Avaliação da expressão de indoleamina 2, 3 dioxigenase - IDO nos leucócitos presentes no tumor ascítico de Ehrlich perante o bloqueio da via de ativação linfocitária B7+CTLA-4
    Carla Simone Soares · 2017
96. Translating immune characteristics of metastatic tumors into therapeutic targets for cervical cancer
    Anne Marijne Heeren · 2018 · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
97. The Addition of Melatonin to 17beta-Estradiol and Progesterone Modulated Markers Relevant to Mammary Tumor Development and Modulated Steroid Receptors Relevant to Uterine Protection in a Mouse Model of Breast Cancer
    Corry D. Bondi · 2013
98. Radiolabeling of protected tryptophan with [18F]fluoromethyl tosylate: Formation of [18F]fluoromethyl ester of tryptophan instead of 1-N-[18F]fluoromethyl tryptophan methylester.
    Taracad K. Venkatachalam, Damion H. R. Stimson, Kim Frisch, Gregory K. Pierens, Rajiv Bhalla, David C. Reutens · 2019 · Applied Radiation and Isotopes
99. Association between endometrial indoleamine 2,3-dioxygenase expression level and pregnancy outcomes in women undergoing first in vitro fertilization treatment
    Su Liu, Hongxia Wei, Yuye Li, Ruochun Lian, Xiaohui Wang, Lanna Chen, Yong Zeng · 2021 · BMC Pregnancy and Childbirth